title: Aortic thrombosis in young women with Crohn's disease receiving adalimumab: report of two cases.
authors.forename: Sarah
authors.initials: S
authors.lastname: Leblanc
authors.forename: Celia
authors.initials: C
authors.lastname: Lloret Linares
authors.forename: Wulfran
authors.initials: W
authors.lastname: Cacheux
authors.forename: Luc
authors.initials: L
authors.lastname: Mouthon
authors.forename: Stanislas
authors.initials: S
authors.lastname: Chaussade
mesh_terms: D000068879:Adalimumab; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D001018:Aortic Diseases / Q000139:chemically induced* / Q000473:pathology; D003424:Crohn Disease / Q000188:drug therapy*; D005260:Female; D006801:Humans; D013927:Thrombosis / Q000139:chemically induced* / Q000473:pathology; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068879:Adalimumab